Innovative approaches to the treatment of type 2 diabetes mellitus: the role of specialized product for enteral nutrition "Glucerna SR"


Cite item

Full Text

Abstract

The feasibility of the use of specialized products for enteral nutrition (EN) for the purpose of glycemic control and blood lipid profiles in patients with diabetes mellitus (DM) is well-founded. The authors performed comparative examination of the magnitude and duration of postprandial glucose (PPG) in 34 patients with type 2 diabetes mellitus (DM2) against the background of consumption of specialized product for the EP "Glucerna SR" and conventional food load. Evaluation of PPG and the areas under the glycemic curves in DM2 patients showed less postalimentary glycemic response as a result of "Glucerna SR" consumption. The findings suggest that specialized product for the EP "Glucerna SR" can be used in the diet of patients with DM2 as an additional source of energy and micronutrients.

References

  1. Аметов А.С., Мельник А.В. Управление сахарным диабетом: роль постпрандиальной гипергликемии и возможности ее коррекции // РМЖ. 2007. № 27(308). С. 2053-58.
  2. Балаболкин М.И., Клебанова Е.М., Креминская В.М. Лечение сахарного диабета и его осложнений: Учебно-методическое пособие. М., ОАО "Издательство "Медицина", 2005. 512 с.
  3. Шарафетдинов Х.Х., Мещерякова В.А., Плотникова О.А. Методология применения пищевых смесей, используемых в энтеральном питании, в диетотерапии больных сахарным диабетом 2 типа // Вопросы питания. 2005. № 4. С. 17-22.
  4. Abbott Nutrition Clinical Protocol №BJ15 Final Report. A randomized, masked, parallel, active treatment controlled, multi-center trial comparing the effect of a one dose challenge of a new liquid diabetes nutritional product versus commercial liquid nutritional products on serum glucose and insulin responses during a meal glucose tolerance test in subjects with type 2 diabetes. Ross Products Division, Abbott Laboratories, 2001.
  5. Coulston AM. Enteral nutrition in the patients with diabetes mellitus Curr Opin Clin Nutr Metab Care 2000;3:11-15.
  6. Diabetes Atlas. Fourth edition / International Diabetes Federation 2009.
  7. Elia M, Ceriello A, Laube H, et al. enteral nutritional support and use of diabetes-specific formulas for patients with diabetes. Diabetes Care 2005;28:2267-79.
  8. Fix BM, Lowe W, Cockram DB, et al. Effect of a liquid nutritional supplement containing novel carbohydrate system on glucose tolerance in subjects with type 2 diabetes. Ann Nutr Metab 2001;45(1):277.
  9. Franz MJ, Horton ES, Bantle JP, et al. Nutrition principles for the management of diabetes and related complications. Diabetes Care 1994;17(5):490-518.
  10. Garg A. High-monounsaturated-fat diets for patients with diabetes mellitus: a meta-analysis. Am J Clin Nutr 1998;67:577-82.
  11. Mata P, Alvarez-Sala LA, et al. Effects of long-term monounsaturated- vs polyunsaturated-enriched diets on lipoproteins in healthy men and women. Am J Clin Nutr 1992;56(1):77-83.
  12. Mata P, Garrido JA, Ordovas JM, et al. Effects of dietary monounsaturated fatty acids on plasma lipoproteins and apolipoproteins in women. Am J Clin Nutr 1992;55(4):846-850.
  13. Mattson FH, Grundy SM. Comparison of effects of dietary saturated, monounsaturated and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res 1985;26(2):194-202.
  14. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103-117.
  15. Shiraiwa T, Kaneto H, Miyatsuka T, et al. Postprandial hyperglycemia is an important predictor of the incidence of diabetic microangiopathy in Japanese type 2 diabetic patients. Biochem Biophys Res Commun 2005;336:.339-345.
  16. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood- glucose control with sulphonylureas or insulin compared with traditional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352:837-53.
  17. Wright J. Total parenteral nutrition and enteral nutrition in diabetes. Curr Opin Clin Nutr Metab Care 2000;3:5-10.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies